XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 60 filers reported holding XENON PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,254,559 | -11.3% | 212,370 | -0.1% | 0.00% | – |
| Q2 2023 | $8,183,175 | +10.2% | 212,550 | +2.5% | 0.00% | – |
| Q1 2023 | $7,424,700 | -52.3% | 207,456 | -47.5% | 0.00% | – |
| Q4 2022 | $15,569,802 | +153.2% | 394,872 | +131.8% | 0.00% | – |
| Q3 2022 | $6,150,000 | +2.5% | 170,371 | -13.6% | 0.00% | – |
| Q2 2022 | $5,999,000 | +14.1% | 197,221 | +14.7% | 0.00% | – |
| Q1 2022 | $5,258,000 | +4.4% | 171,987 | +6.7% | 0.00% | – |
| Q4 2021 | $5,037,000 | +123.6% | 161,249 | +9.4% | 0.00% | – |
| Q3 2021 | $2,253,000 | -7.4% | 147,447 | +12.9% | 0.00% | – |
| Q2 2021 | $2,432,000 | +38.5% | 130,595 | +33.1% | 0.00% | – |
| Q1 2021 | $1,756,000 | +22.3% | 98,088 | +5.0% | 0.00% | – |
| Q4 2020 | $1,436,000 | +44.9% | 93,386 | +4.3% | 0.00% | – |
| Q3 2020 | $991,000 | -8.8% | 89,547 | +3.3% | 0.00% | – |
| Q2 2020 | $1,087,000 | +405.6% | 86,664 | +356.7% | 0.00% | – |
| Q1 2020 | $215,000 | -19.5% | 18,978 | -6.8% | 0.00% | – |
| Q4 2019 | $267,000 | +43.5% | 20,360 | -1.5% | 0.00% | – |
| Q3 2019 | $186,000 | -8.8% | 20,664 | 0.0% | 0.00% | – |
| Q2 2019 | $204,000 | -2.9% | 20,664 | 0.0% | 0.00% | – |
| Q1 2019 | $210,000 | +56.7% | 20,664 | -2.9% | 0.00% | – |
| Q4 2018 | $134,000 | -47.9% | 21,288 | +9.2% | 0.00% | – |
| Q3 2018 | $257,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |